|
KR100477070B1
(ko)
|
1994-03-25 |
2006-04-21 |
이소테크니카 인코포레이티드 |
중수소화작용에의한의약품의효능강화법
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
TW200418829A
(en)
*
|
2003-02-14 |
2004-10-01 |
Avanir Pharmaceutics |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
|
|
AU2004220176A1
(en)
|
2003-03-14 |
2004-09-23 |
Astrazeneca Ab |
Novel fused triazolones and the uses thereof
|
|
GB0420970D0
(en)
|
2004-09-21 |
2004-10-20 |
Smithkline Beecham Corp |
Novel triazoloquinoline compounds
|
|
AR064416A1
(es)
*
|
2006-12-21 |
2009-04-01 |
Cancer Rec Tech Ltd |
Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
|
|
WO2011075747A1
(en)
|
2009-12-18 |
2011-06-23 |
Glaxosmithkline Llc |
Therapeutic compounds
|
|
US10376504B2
(en)
*
|
2015-07-29 |
2019-08-13 |
Merck, Sharp & Dohme Corp. |
Substituted quinolinones as PDE9 inhibitors
|
|
CN111406050B
(zh)
*
|
2018-01-17 |
2023-02-03 |
厦门宝太生物科技股份有限公司 |
吲哚胺2,3-双加氧酶抑制剂及其用途
|
|
SG11202012973RA
(en)
|
2018-06-27 |
2021-01-28 |
Bristol Myers Squibb Co |
Naphthyridinone compounds useful as t cell activators
|
|
CN112654621B
(zh)
|
2018-06-27 |
2024-05-14 |
百时美施贵宝公司 |
可作为t细胞活化剂的经取代萘啶酮化合物
|
|
MA56444A
(fr)
|
2019-07-04 |
2022-05-11 |
Lead Pharma Holding Bv |
MODULATEURS DU RÉCEPTEUR ALPHA DES OESTROGÈNES (ERRalpha)
|
|
AR119821A1
(es)
|
2019-08-28 |
2022-01-12 |
Bristol Myers Squibb Co |
Compuestos de piridopirimidinonilo sustituidos útiles como activadores de células t
|
|
HRP20240237T1
(hr)
|
2019-10-18 |
2024-05-10 |
Lead Pharma Holding B.V. |
Modulatori receptora alfa (err-alfa) povezanih s estrogenom
|
|
US12478621B2
(en)
*
|
2019-11-28 |
2025-11-25 |
Deutsches Krebsforschungszentrum |
Substituted aminoquinolones as dgkalpha inhibitors for immune activation
|
|
WO2021105115A1
(en)
|
2019-11-28 |
2021-06-03 |
Bayer Aktiengesellschaft |
Substituted aminoquinolones as dgkalpha inhibitors for immune activation
|
|
EP4065584A1
(en)
|
2019-11-28 |
2022-10-05 |
Bayer Aktiengesellschaft |
Substituted aminoquinolones as dgkalpha inhibitors for immune activation
|
|
WO2021127554A1
(en)
|
2019-12-19 |
2021-06-24 |
Bristol-Myers Squibb Company |
Combinations of dgk inhibitors and checkpoint antagonists
|
|
CA3162979A1
(en)
|
2019-12-23 |
2021-07-01 |
Upender Velaparthi |
Substituted piperazine derivatives useful as t cell activators
|
|
MX2022007369A
(es)
|
2019-12-23 |
2022-07-12 |
Bristol Myers Squibb Co |
Compuestos de quinolinonilo piperazina sustituidos utiles como activadores de celulas t.
|
|
IL294148A
(en)
|
2019-12-23 |
2022-08-01 |
Bristol Myers Squibb Co |
Substituted quinazolinyl compounds are useful as t-cell activators
|
|
JP7677976B2
(ja)
*
|
2019-12-23 |
2025-05-15 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｔ細胞アクティベーターとして有用な置換ヘテロアリール化合物
|
|
AR120823A1
(es)
|
2019-12-23 |
2022-03-23 |
Bristol Myers Squibb Co |
Compuestos bicíclicos sustituidos útiles como activadores de células t
|
|
CN115362003B
(zh)
|
2019-12-24 |
2024-03-22 |
卡尔那生物科学株式会社 |
二酰基甘油激酶调节化合物
|
|
WO2021258010A1
(en)
|
2020-06-19 |
2021-12-23 |
Gossamer Bio Services, Inc. |
Oxime compounds useful as t cell activators
|
|
AU2021400725A1
(en)
|
2020-12-16 |
2023-08-03 |
Gossamer Bio Services, Inc. |
Compounds useful as t cell activators
|
|
CN117355531A
(zh)
|
2021-06-23 |
2024-01-05 |
吉利德科学公司 |
二酰基甘油激酶调节化合物
|
|
JP7651018B2
(ja)
|
2021-06-23 |
2025-03-25 |
ギリアード サイエンシーズ， インコーポレイテッド |
ジアシルグリセロールキナーゼ調節化合物
|
|
EP4359413A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
MX2023014762A
(es)
|
2021-06-23 |
2024-01-15 |
Gilead Sciences Inc |
Compuestos moduladores de diacilglicerol quinasa.
|
|
CA3228862A1
(en)
|
2021-08-03 |
2023-02-09 |
Beigene, Ltd. |
Pyrazolopyridinone compounds
|
|
WO2023165528A1
(en)
|
2022-03-01 |
2023-09-07 |
Insilico Medicine Ip Limited |
Diacylglycerol kinase (dgk) alpha inhibitors and uses thereof
|
|
EP4486745A4
(en)
|
2022-03-01 |
2026-03-11 |
Insilico Medicine Ip Ltd |
Diacylglycerol Kinase (DGK) Alpha Inhibitors and Their Uses
|
|
WO2023165525A1
(en)
|
2022-03-01 |
2023-09-07 |
Insilico Medicine Ip Limited |
Diacylglycerol kinase (dgk) alpha inhibitors and uses thereof
|
|
IL315015A
(en)
|
2022-03-01 |
2024-10-01 |
Insilico Medicine Ip Ltd |
Diacylglycerol kinase (DGK) alpha inhibitors and their uses
|
|
JP2025510945A
(ja)
|
2022-03-31 |
2025-04-15 |
インベンティスバイオ カンパニー リミテッド |
キナーゼ阻害剤、その製造方法および用途
|
|
WO2023184327A1
(en)
|
2022-03-31 |
2023-10-05 |
InventisBio Co., Ltd. |
Kinase inhibitors, preparation methods and uses thereof
|